Hironic Co. Ltd
Hironic Co., Ltd. engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally. It offers its products for the MFU and RF, laser, plasma, and cryotherapy. The company was founded in 2007 and is headquartered in Yongin-Si, South Korea.
Hironic Co. Ltd (149980) - Net Assets
Latest net assets as of December 2024: ₩69.84 Billion KRW
Based on the latest financial reports, Hironic Co. Ltd (149980) has net assets worth ₩69.84 Billion KRW as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩80.01 Billion) and total liabilities (₩10.18 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩69.84 Billion |
| % of Total Assets | 87.28% |
| Annual Growth Rate | 4.07% |
| 5-Year Change | 67.87% |
| 10-Year Change | 58.98% |
| Growth Volatility | 13.14 |
Hironic Co. Ltd - Net Assets Trend (2014–2024)
This chart illustrates how Hironic Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Hironic Co. Ltd (2014–2024)
The table below shows the annual net assets of Hironic Co. Ltd from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩69.84 Billion | -3.54% |
| 2023-12-31 | ₩72.40 Billion | +23.40% |
| 2022-12-31 | ₩58.67 Billion | +4.87% |
| 2021-12-31 | ₩55.95 Billion | +34.49% |
| 2020-12-31 | ₩41.60 Billion | +2.16% |
| 2019-12-31 | ₩40.72 Billion | +7.87% |
| 2018-12-31 | ₩37.75 Billion | -5.39% |
| 2017-12-31 | ₩39.91 Billion | -6.76% |
| 2016-12-31 | ₩42.80 Billion | -2.57% |
| 2015-12-31 | ₩43.93 Billion | -6.27% |
| 2014-12-31 | ₩46.87 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Hironic Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 174.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩36.44 Billion | 52.24% |
| Other Components | ₩33.32 Billion | 47.76% |
| Total Equity | ₩69.77 Billion | 100.00% |
Hironic Co. Ltd Competitors by Market Cap
The table below lists competitors of Hironic Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Younglimwon Soft Lab Co. Ltd.
KQ:060850
|
$23.73 Million |
|
Sun A.Kaken CompanyLimited
F:KK2
|
$23.73 Million |
|
3i Infotech Limited
NSE:3IINFOLTD
|
$23.73 Million |
|
Infas Holding AG
F:IFS
|
$23.73 Million |
|
Performance Shipping Inc
NASDAQ:PSHG
|
$23.71 Million |
|
IRM ENERGY LTD
NSE:IRMENERGY
|
$23.70 Million |
|
Beijing Energy International Holding Co. Ltd
PINK:PVLTF
|
$23.70 Million |
|
IKIO Lighting Limited
NSE:IKIO
|
$23.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hironic Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 72,293,020,980 to 69,766,178,850, a change of -2,526,842,130 (-3.5%).
- Net loss of 5,454,070,200 reduced equity.
- Share repurchases of 7,243,575,260 reduced equity.
- New share issuances of 23,192,450 increased equity.
- Other factors increased equity by 10,147,610,880.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-5.45 Billion | -7.82% |
| Share Repurchases | ₩7.24 Billion | -10.38% |
| Share Issuances | ₩23.19 Million | +0.03% |
| Other Changes | ₩10.15 Billion | +14.55% |
| Total Change | ₩- | -3.50% |
Book Value vs Market Value Analysis
This analysis compares Hironic Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.16x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.60x to 1.16x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩3189.40 | ₩5090.00 | x |
| 2017-12-31 | ₩3086.80 | ₩5090.00 | x |
| 2018-12-31 | ₩3004.58 | ₩5090.00 | x |
| 2019-12-31 | ₩3239.53 | ₩5090.00 | x |
| 2020-12-31 | ₩3373.07 | ₩5090.00 | x |
| 2021-12-31 | ₩4123.97 | ₩5090.00 | x |
| 2022-12-31 | ₩4323.28 | ₩5090.00 | x |
| 2023-12-31 | ₩4297.85 | ₩5090.00 | x |
| 2024-12-31 | ₩4370.40 | ₩5090.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hironic Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.82%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -17.24%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 1.15x
- Recent ROE (-7.82%) is below the historical average (5.32%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 13.76% | 28.26% | 0.43x | 1.14x | ₩1.76 Billion |
| 2015 | 6.45% | 15.81% | 0.39x | 1.04x | ₩-1.56 Billion |
| 2016 | 1.68% | 4.64% | 0.35x | 1.04x | ₩-3.56 Billion |
| 2017 | 1.91% | 4.21% | 0.36x | 1.25x | ₩-3.23 Billion |
| 2018 | -0.69% | -1.28% | 0.47x | 1.14x | ₩-4.04 Billion |
| 2019 | 7.13% | 14.43% | 0.43x | 1.15x | ₩-1.17 Billion |
| 2020 | 7.64% | 24.47% | 0.29x | 1.08x | ₩-982.60 Million |
| 2021 | 12.11% | 31.11% | 0.34x | 1.14x | ₩1.18 Billion |
| 2022 | 5.00% | 10.64% | 0.41x | 1.15x | ₩-2.93 Billion |
| 2023 | 11.38% | 24.38% | 0.43x | 1.09x | ₩995.32 Million |
| 2024 | -7.82% | -17.24% | 0.40x | 1.15x | ₩-12.43 Billion |
Industry Comparison
This section compares Hironic Co. Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $104,721,373,964
- Average return on equity (ROE) among peers: 7.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hironic Co. Ltd (149980) | ₩69.84 Billion | 13.76% | 0.15x | $23.71 Million |
| Shinhung (004080) | $87.31 Billion | 3.50% | 0.52x | $10.80 Million |
| Osang Healthcare Co.,Ltd (036220) | $199.86 Billion | 20.34% | 0.25x | $37.44 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $246.58 Million |
| JVM Co. Ltd (054950) | $98.83 Billion | 10.23% | 0.72x | $117.37 Million |
| Huvitz Co. Ltd (065510) | $51.68 Billion | 16.97% | 0.32x | $43.64 Million |
| Vieworks Co. Ltd (100120) | $188.04 Billion | 17.80% | 0.28x | $101.54 Million |
| Corentec Co Ltd (104540) | $48.30 Billion | -3.04% | 0.46x | $40.80 Million |
| Laseroptek Co., Ltd. (199550) | $-3.94 Billion | 0.00% | 0.00x | $21.68 Million |
| Humasis Co. Ltd (205470) | $229.26 Billion | -13.28% | 0.45x | $48.97 Million |